MIRA INFORM REPORT

 

 

Report Date :

09.06.2012

 

IDENTIFICATION DETAILS

 

Name :

SWETA PHARMA PRIVATE LIMITED

 

 

Registered Office :

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

19.06.1981

 

 

Com. Reg. No.:

11-024656

 

 

Capital Investment / Paid-up Capital :

Rs.0.222 Million

 

 

CIN No.:

[Company Identification No.]

U24239MH1981PTC024656

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Importer and Trader of Pharmaceuticals Raw Material and Excipients Products.

 

 

No. of Employees :

9 (Approximately) ( In Office)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (31)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 12000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appears some dip in the turnover of the company in the current year. However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOCATIONS

 

Registered Office :

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, Maharashtra, India

Tel. No.:

91-22-22010336

Fax No.:

91-22-22076974

E-Mail :

khimani@amoliindia.com

Area :

1100sq.fts

Location:

Owned

 

 

Corporate office :

11, Mansoor Building, 98, Princess Street, Mumbai – 400002, Maharashtra, India

Location:

Owned

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Mr. Manish Umed Doshi

Designation :

Director

Address :

1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

07.10.1961

Date of Appointment :

12.08.1997

DIN No. :

00210389

 

Name :

Mrs. Vandana Manish Doshi

Designation :

Director

Address :

1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

23.08.1962

Date of Appointment :

20.03.1985

DIN No. :

00211618

 

Name :

Mr. Bimal Kumar Shantilal Doshi

Designation :

Director

Address :

Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

24.01.1964

Date of Appointment :

02.09.2003

DIN No. :

00978718

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2011

 

Names of Shareholders

 

No. of Shares

Ramesh B. Doshi

 

1

Vinod B. Doshi

 

1

Navin V. Doshi

 

1

Sweta U. Doshi

 

5

Vandana M. Doshi

 

1702

Umed B. Doshi

 

10

Amoli M. Doshi

 

200

Manish U. Doshi

 

100

Manish U. Doshi (HUF)

 

100

Indu U. Doshi

 

100

Total

 

2220

 

AS ON 30.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Importer and Trader of Pharmaceuticals Raw Material and Excipients Products.

 

 

GENERAL INFORMATION

 

No. of Employees :

9 (Approximately) ( In Office)

 

 

Bankers :

Indian Overseas Bank, Merchant Chamber, Ground Floor, Opp. SNDT College, New Marine Lines, Mumbai – 400020, Maharashtra, India

 

 

Facilities :

 

Unsecured Loans

31.03.2011

(Rs. in Millions)

31.03.2010

(Rs. in Millions)

From Banks

0.000

2.417

From Others

10.293

9.152

Total

10.293

11.569

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Pradip Shah and Associates

Chartered Accountants

Address :

F. No. 4, Sunbean Chambers, Sir V. Thakersey Marg, Marine Lines, Mumbai – 400020, Maharashtra, India

Tel. No.:

91-22-66550627 / 28 / 22091716

PAN No.:

AADPS8414P

 

 

Associates :

·         Amoli Organics Limited

·         Chemphar

·         Umedica Laboratories Private Limited

·         Bharat Mercantile Company

 


 

CAPITAL STRUCTURE

 

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000

Equity Shares

Rs.100/- each

Rs.0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2220

Equity Shares

Rs.100/-each

Rs.0.222 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.222

0.222

0.222

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

2.776

1.492

0.032

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2.998

1.714

0.254

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

10.293

11.569

5.873

TOTAL BORROWING

10.293

11.569

5.873

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

13.291

13.283

6.127

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.331

0.352

0.406

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.010

0.010

0.010

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

2.682
2.513

5.908

 

Sundry Debtors

6.608
11.837

13.184

 

Cash & Bank Balances

0.257
0.052

0.250

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

22.709
18.741

9.467

Total Current Assets

32.256
33.143

28.809

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

13.015
17.305

20.916

 

Other Current Liabilities

4.379
2.134

1.804

 

Provisions

1.912
0.783

0.378

Total Current Liabilities

19.306
20.222

23.098

Net Current Assets

12.950
12.921

5.711

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

13.291

13.283

6.127

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

19.434

44.690

56.409

 

 

Income from Operating Activities

0.244

0.043

0.155

 

 

Other Income

5.967

9.349

1.911

 

 

TOTAL                                    

25.645

54.082

58.475

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

23.759

52.195

58.936

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

1.886

1.887

(0.461)

 

 

 

 

 

Less

TAX                                                                 

0.602

0.427

0.037

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX                          

1.284

1.460

(0.498)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

19.433

44.041

56.408

 

TOTAL EARNINGS

19.433

44.041

56.408

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

578.38

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

5.01
2.70

(0.85)

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

9.70

4.22

(0.82)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.79
5.63

(1.58)

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.63
1.10

(1.81)

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

9.87
18.54

114.06

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.67
1.64

1.25

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

Yes

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter's background

Yes

8) No. of employees

Yes

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

 

BANKERS CHARGES REPORT AS PER REGISTRY:

 

Corporate identity number of the company

U24239MH1981PTC024656

Name of the company

SWETA PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, Maharashtra, India

E-mail : khimani@amoliindia.com

This form is for

Creation of charge

Type of charge

Book Debts

Movable property

Particular of charge holder

Indian Overseas Bank, Merchant Chamber, Ground Floor, Opp. SNDT College, New Marine Lines, Mumbai – 400020, Maharashtra, India

Nature of instrument creating charge

Letter of Hypothecation (For securing Machineries/Vehicles/Goods/Book-Debts).

Date of instrument Creating the charge

26.04.2011

Amount secured by the charge

Rs.8.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest :

Cash Credit: Base Rate + 3.75%.

 

Terms of repayment :

As per Sanction Letter.

 

Margin :

Letter of Credit-Inland and Foreign (DP/DA upto 90 days) :- 25%

Sublimit- Clean Cash Credit against Stock and Book Debts (upto 60 days) :- 25% on Stock and 50% on Book Debts.

 

Extent and operation of the charge :

Exclusive charge by hypothecation of Documents of title to goods /accepted hundies / stock / Book debts present and future.

 

Others :

Letter of Credit facility of Rs. 8.000 millions with sub-limit Clean Cash Credit of Rs. 0.500 million.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Exclusive charge by hypothecation of Documents of title to goods /accepted hundies / stock / Book debts present and future

 

FIXED ASSETS

 

  • Air conditioner
  • Motor Car
  • Computer
  • Fax Machine
  • Printer
  • Vehicle
  • Tea Machine
  • Furniture

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.36

UK Pound

1

Rs.85.64

Euro

1

Rs.69.21

 

 

INFORMATION DETAILS

 

Report Prepared by :

BSN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

31

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.